Study Finds Endoscopic Submucosal Dissection as a Safe Alternative to Surgery for Early Gastric Cancer in Patients Under 45

A recent study published in *BMC Cancer* has presented findings that suggest endoscopic submucosal dissection (ESD) is a viable and safe alternative to traditional surgical treatment for early gastric cancer (EGC) in patients under the age of 45. The research highlights ESD as an effective option for younger individuals diagnosed with EGC, offering comparable outcomes to surgery while potentially reducing invasiveness.

The study examined the efficacy and safety of ESD compared to conventional surgical methods, focusing on survival rates and post-treatment recovery among young patients. Researchers analyzed data from individuals under 45 years old who underwent either ESD or surgery for early-stage gastric cancer. The results indicate that ESD provides similar survival outcomes to surgery while minimizing complications associated with more invasive procedures. These findings could influence treatment approaches for younger patients diagnosed with EGC, emphasizing less invasive options without compromising effectiveness.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 22, 2025

Related posts:

DrugPatentWatch.com Article: Market Research and Strong Stakeholder Relationships Key to Successful Generic Drug Launches. Novo Nordisk Partners with Septerna in $2.2 Billion Deal to Develop Oral Obesity Drugs Early Immunotherapy Found Crucial in Managing Anti-IgLON5 Disease Progression New Definition of Obesity Classifies 70 Percent of US Adults as Obese

Author

GOAI